C6Y-44648-33152
2 vaccinations
4 coded responses
23 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 056 / VT
- Registered
- 2022-06-23
- Relationship
- Child or adolescent in my care
- Guardian
- MB7-27850-52595
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-23
Registered in v-safe
-
2022-07-05
Dose 1 — Moderna
- 2022-07-05
- 2022-07-06
- 2022-07-07
- 2022-07-08
- 2022-07-09
- 2022-07-10
- 2022-07-11
- 2022-07-12
- 2022-07-19
- 2022-07-26
- 2022-08-02
- 2022-08-09
-
2022-08-18
Survey response — day 42, dose 1, under 3MedDRA: Diarrhoea — Feeling: FairFree text: Diarrhea x 4 days this last weekMedDRA releases: 2024-11 · check-in free text available
-
2022-10-06
Survey response — 3 months, dose 1, under 3MedDRA: Ear infection, Respiratory syncytial virus infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: RSV and ear infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-10-06
Report sent to call center — 3 months, dose 1, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-07
- 2023-01-05
-
2023-03-22
Dose 2 — Moderna
-
2023-03-23
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Fatigue — Feeling: Fair · Site: Pain · Fever · Sleepiness, Loss of appetite · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-03-24
-
2023-03-25
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
- 2023-03-26
- 2023-03-28
- 2023-03-31
- 2023-04-05
-
2023-04-12
Survey response — day 21, dose 2, under 3MedDRA: Nasopharyngitis, Urticaria — Feeling: FairMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-05 | Moderna | No |
| 2 | 2023-03-22 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 (Under 3) — day 42, dose 1, under 3
Symptoms: Diarrhea x 4 days this last week
Release 12 (Under 3) — 3 months, dose 1, under 3
Symptoms: RSV and ear infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
| SRO | Fatigue | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release